如何写render to responsee to review comments

&& 查看话题
如何写 response to review comments
各位,我的审稿意见是英文太差,文章组织太差,我修改论文,基本上
1. 把很多段落都删掉了,然后增加了很多段落,
2. 很多地方都修改了,包括语法、单词、句式。
3. 重新组织了文章的结构
4. 几乎是重新写了一遍论文
怎么回那个 response to review comments啊,各位,帮忙啊,难道要我把每一个修改都对应 哪一行 哪一列 写上去么?
我的论文等于重新写了一遍,哪位有经验,给点建议。谢谢。
怎么没人回帖子啊,是不是大家都没什么经验啊,不对啊,这里高手很多啊 简单回答一句就好,就说找个native english的修改了语法,看修改稿 逐条写上意见,逐条对应回答。哪些地方删了,就写删掉了。哪些地方加上了新段落就写在哪里新加了就行了。 把主要的修改地方列出来,比如说大段的删除和添加等
单词、语法之类的小修改就不用一个个列出来了,就一句话带过,说英语经过了修改和提高 谢谢各位,我觉得还是楼上的方法比较好
var cpro_id = 'u1216994';
欢迎监督和反馈:本帖内容由
提供,小木虫仅提供交流平台,不对该内容负责。欢迎协助我们监督管理,共同维护互联网健康,如果您对该内容有异议,请立即发邮件到
联系通知管理员,也可以通过QQ周知,我们的QQ号为:8835100
我们保证在1个工作日内给予处理和答复,谢谢您的监督。
小木虫,学术科研第一站,为中国学术科研研究提供免费动力
广告投放请联系QQ: &
违规贴举报删除请联系邮箱: 或者 QQ:8835100
Copyright &
eMuch.net, All Rights Reserved. 小木虫 版权所有58cv网址导航Overnight response to infliximab in neurosarcoidosis: a case report...
- PubMed - NCBI
The NCBI web site requires JavaScript to function.
FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListApplyChoose DestinationFileClipboardCollectionsE-mailOrderMy BibliographyCitation managerFormatSummary (text)Abstract (text)MEDLINEXMLPMID ListCSVCreate File1 selected item: FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListMeSH and Other DataE-mailSubjectAdditional textE-mailAdd to ClipboardAdd to CollectionsOrder articlesAdd to My BibliographyGenerate a file for use with external citation management software.Create File
2014 Sep-O37(5):142-8. doi: 10.1097/WNF.0047.Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice.1, , , , .1Departments of *Neurology, and +Rheumatology, Rikshospitalet, Oslo University H and ?University of Oslo, Oslo, Norway.AbstractOBJECTIVES: Central nervous system manifestations of sarcoidosis occur in approximately 5% of patients with sarcoidosis, often lead to substantial morbidity, and therefore require immediate treatment. Spinal cord involvement is exceptionally rare. The tumor necrosis factor-α inhibitor infliximab seems to be an effective alternative in severe cases, refractory to other therapies, but a standard concept of treatment is lacking.METHODS: We presented a case of severe corticosteroid-refractory spinal cord sarcoidosis with immediate and dramatic response to infliximab. In addition, we reviewed the literature on infliximab therapy in neurosarcoidosis and drew parallels to other medical fields in order to have a basis for decision making in the initiation and discontinuation of treatment.RESULTS: We identified a total of 34 case reports on effective infliximab treatment of therapy-resistant neurosarcoidosis through PubMed search. Nineteen of the 34 cases reported the duration until treatment response. In accordance with our patient, 14 of the 34 case reports showed improvement between first and third infusion. Eight of the 34 cases reported sustained remission after cessation of infliximab. No definite treatment regimen was used.CONCLUSIONS: Infliximab seems to be a fast-acting and effective drug for severe neurosarcoidosis. No systematic treatment strategy is available because of lack of controlled trials. Until then, therapy regimens may be adapted to those used in other medical fields where infliximab treatment is well established.PMID:
[PubMed - in process]
Full Text SourcesOther Literature Sources
Supplemental Content
External link. Please review our .Government response to Shakespeare review - Publications - GOV.UK
GOV.UK uses cookies to make the site simpler.
The government's response to the Shakespeare review of public services, which explores new ways to use public sector information.
PDF, 968KB, 44 pages
ODT, 190KB
This file is in an
A key commitment in last year’s
was the commission of an independent review of public sector information (PSI) which was launched in October 2012.
This review was launched in October 2012 by Stephan Shakespeare, Chair of the Data Strategy Board and CEO of YouGov, who we asked to look at our progress so far on opening up public data and to set out his assessment of how the government should best use PSI to support economic growth.
was published on 15 May 2013.
This is the government’s detailed response to the report’s conclusions and recommendations.
Help us improve GOV.UK
Don't include personal or financial information, eg your National Insurance number or credit card details.
What you were doing
What went wrong

我要回帖

更多关于 如何写review 的文章

 

随机推荐